ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Development and validation of a [18F]FDG PET/CT-based radiomics nomogram to predict the prognostic risk of pretreatment diffuse large B cell lymphoma patients

Li, Mingshan; Yao, Hongyang; Zhang, Peng; Zhang, Lingbo; Liu, Wei; Jiang, Zhiyun; Li, Wei; Zhao, Shu*; Wang, Kezheng*哈尔滨医科大学
European Radiology2023-5DOI: 10.1007/s00330-022-09301-5
3被引8阅读
引用收藏
分享

摘要

Objective In this study, based on PET/CT radiomics features, we developed and validated a nomogram to predict progression-free survival (PFS) for cases with diffuse large B cell lymphoma (DLBCL) treated with immunochemotherapy. Methods This study retrospectively recruited 129 cases with DLBCL. Among them, PET/CT scans were conducted and baseline images were collected for radiomics features along with their clinicopathological features. Radiomics features related to recurrence were screened for survival analysis using univariate Cox regression analysis with p < 0.05. Next, a weighted Radiomics-score (Rad-score) was generated and independent risk factors were obtained from univariate and multivariate Cox regressions to build the nomogram. Furthermore, the nomogram was tested for their ability to predict PFS using time-dependent receiver operating characteristic (ROC) curves, calibration curves, and decision curve analysis (DCA). Results Blood platelet, Rad-score, and gender were included in the nomogram as independent DLBCL risk factors for PFS. We found that the training cohort areas under the curve (AUCs) were 0.79, 0.84, and 0.88, and validation cohort AUCs were 0.67, 0.83, and 0.72, respectively. Further, the DCA and calibration curves confirmed the predictive nomogram's clinical relevance. Conclusion Using Rad-score, blood platelet, and gender of the DLBCL patients, a PET/CT radiomics-based nomogram was developed to guide cases' recurrence risk assessment prior to treatment. The developed nomogram can help provide more appropriate treatment plans to the cases.

学科与关键词

关键词
[F-18]FDG PETCTRadiomicsDiffuse large B cell lymphomaProgression-free survivalNomogram
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
European Radiology
发表日期
2023-05
卷期
第 33 卷, 第 5 期
页码
3354-3365
DOI
10.1007/s00330-022-09301-5
语言
ENGLISH
成果收录
SCIE
资助标注
National Natural Science Foundation of China; Provincial Key Research and Development Program of Heilongjiang Province [81571740]; Postdoctoral Special Scientific Research Grantof Heilongjiang Provincial Government [GA21C001]; Distinguished Young Scientist Funding of Harbin Medical University Affiliated Tumor Hospital [LBH-Q17104]; Key Project of the Climbing Funding of the National Cancer Center [JCQN2019-02]; Beijing Medical Award Foundation [NCC201808B019]; Harbin Medical University CancerHospital Haiyan Scientific Research Fund [YXJL-2020-0785-1072]; [JJZD 2022-10]

作者

  • L

    Li, Mingshan (第一作者)

    harbin med univ

  • Y

    Yao, Hongyang

    harbin med univ

查看全部 9 位作者收起作者
  • Z

    Zhang, Peng

    harbin med univ

  • Z

    Zhang, Lingbo

    2 · harbin med univ

  • L

    Liu, Wei

  • J

    Jiang, Zhiyun

    harbin med univ

  • L

    Li, Wei

  • Z

    Zhao, Shu (通讯)

    harbin med univ

  • W

    Wang, Kezheng (通讯)

    harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417